Cadence Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-7,120
| Closed | -$1.24M | – | 314 |
|
|
2020
Q2 | $1.24M | Buy |
7,120
+11
| +0.2% | +$1.92K | 0.18% | 180 |
|
|
2020
Q1 | $897K | Sell |
7,109
-183
| -3% | -$23.1K | 0.15% | 212 |
|
|
2019
Q4 | $1.11M | Sell |
7,292
-1,377
| -16% | -$210K | 0.12% | 241 |
|
|
2019
Q3 | $1.15M | Sell |
8,669
-196
| -2% | -$26K | 0.16% | 231 |
|
|
2019
Q2 | $1.26M | Sell |
8,865
-15
| -0.2% | -$2.13K | 0.13% | 234 |
|
|
2019
Q1 | $1.29M | Sell |
8,880
-2,724
| -23% | -$396K | 0.12% | 237 |
|
|
2018
Q4 | $1.31M | Sell |
11,604
-1,538
| -12% | -$174K | 0.13% | 224 |
|
|
2018
Q3 | $1.77M | Buy |
13,142
+873
| +7% | +$117K | 0.1% | 292 |
|
|
2018
Q2 | $1.38M | Sell |
12,269
-4,680
| -28% | -$525K | 0.08% | 323 |
|
|
2018
Q1 | $1.81M | Sell |
16,949
-276
| -2% | -$29.5K | 0.12% | 222 |
|
|
2017
Q4 | $1.89M | Sell |
17,225
-275
| -2% | -$30.1K | 0.12% | 207 |
|
|
2017
Q3 | $1.89M | Hold |
17,500
| – | – | 0.12% | 203 |
|
|
2017
Q2 | $1.77M | Buy |
17,500
+2,670
| +18% | +$270K | 0.12% | 198 |
|
|
2017
Q1 | $1.33M | Buy |
14,830
+6,853
| +86% | +$616K | 0.09% | 254 |
|
|
2016
Q4 | $608K | Sell |
7,977
-11,930
| -60% | -$909K | 0.04% | 463 |
|
|
2016
Q3 | $1.66M | Sell |
19,907
-11
| -0.1% | -$917 | 0.12% | 208 |
|
|
2016
Q2 | $1.64M | Buy |
19,918
+2,810
| +16% | +$232K | 0.12% | 202 |
|
|
2016
Q1 | $1.3M | Sell |
17,108
-874
| -5% | -$66.4K | 0.09% | 252 |
|
|
2015
Q4 | $1.45M | Sell |
17,982
-224
| -1% | -$18K | 0.1% | 232 |
|
|
2015
Q3 | $1.16M | Buy |
+18,206
| New | +$1.16M | 0.08% | 260 |
|